Advertisement

Topics

Fresenius Kabi Eyes Precedex Premix Market As US Court Axes Two Patents

00:56 EST 21 Dec 2018 | SCRIP

Looking to bolster its portfolio of generic sedative injectables, Fresenius Kabi squared off with Pfizer’s Hospira in court, alleging that...

      

Related Stories

 

Original Article: Fresenius Kabi Eyes Precedex Premix Market As US Court Axes Two Patents

NEXT ARTICLE

More From BioPortfolio on "Fresenius Kabi Eyes Precedex Premix Market As US Court Axes Two Patents"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...